4 results match your criteria: "University of Wisconsin-Madison Alzheimer's Disease Research Center[Affiliation]"
Alzheimers Dement
January 2024
University of Wisconsin-Madison Waisman Center, Madison, Wisconsin, USA.
Neuroimage Clin
September 2021
University of Wisconsin-Madison Waisman Center, Madison, WI, USA; University of Wisconsin-Madison Department of Medical Physics, Madison, WI, USA.
Introduction: Adults with Down syndrome are genetically predisposed to develop Alzheimer's disease and accumulate beta-amyloid plaques (Aβ) early in life. While Aβ has been heavily studied in Down syndrome, its relationship with neurofibrillary tau is less understood. The aim of this study was to evaluate neurofibrillary tau deposition in individuals with Down syndrome with varying levels of Aβ burden.
View Article and Find Full Text PDFIntroduction: Adults with Down syndrome (DS) are predisposed to Alzheimer's disease (AD) and the relationship between cognition and glucose metabolism in this population has yet to be evaluated.
Methods: Adults with DS (N = 90; mean age [standard deviation] = 38.0 [8.
: Informed consent (IC) is critical to performing ethical research. Unfortunately, the IC process and supporting IC forms are frequently burdensome and do not necessarily meet the informational needs of participants. The intersecting legal and ethical challenges of obtaining IC from individuals with memory or cognitive deficits further exacerbate existing IC shortcomings.
View Article and Find Full Text PDF